Hedge Funds Eye SmallCap Biotech Stocks for Potential Growth VISN Q1 2026 Earnings EPS Surges 7094 Above Expectations Driving Stock Gains Versant Stock Surges 10 on Q1 Results Highlighting Licensing and Platform Strength